A pilot study of developing a programme to reduce duplicate medications with chronic disease conditions
- At: 2016 FIP Congress in Buenos Aires (Argentina)
- Type: Poster
- By: LIN, Pei-Tzu (Chiayi Chang Gung Memorial Hospital of the C.G.M.F., Department of Pharmacy, Chiayi, China Taiwan)
- Co-author(s): Pei-Tzu Lin:
Medication duplication would harm to patient, exacerbate the disease, increase medicine expenditure and not improve treatment outcomes. Analyzing the inappropriate prescriptions in Chiayi CGMH on 2012, 68.8% of duplicate medications were intercepted by pharmacist. There still have some space to improve the drug safety.
Using SAS-EG the medicine.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.